BioSpace News Archive

Policy

NuVasive Comments on Expected Impact of U.S. Tax Reform

Based on the preliminary assessment of the legislation, the Company believes the new regulations will positively impact its non-GAAP EPS.

December 21, 2017

·

4 min read

Pharm Country

Q BioMed Inc. Provides Year End Update

Q Biomed is pleased to provide this year end update to its shareholders.

December 21, 2017

·

9 min read

Drug Development

Jazz Pharma Submits NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated With Narcolepsy and Obstructive Sleep Apnea

Jazz Pharma today announced the submission of a NDA to the FDA on December 20, 2017.

December 21, 2017

·

6 min read

Business

PolyPid Appoints Jacob Harel as Chairman of the Board of Directors

PolyPid today announced that Jacob Harel, a seasoned business development executive with more than 30 years of experience in the global pharmaceutical industry, has been appointed as Chairman of the Company’s Board of Directors, following his recent election as a director by the Company’s shareholders.

December 21, 2017

·

3 min read

Business

Invitae Chairman Randy Scott Joins Freenome Board of Directors

For nearly three decades, Dr. Scott has been an entrepreneur and visionary leader in genomic medicine.

December 21, 2017

·

2 min read

Acasti Pharma Announces Pricing of US$10 Million Offering of Common Shares and Warrants

Acasti Pharma announced the pricing of its underwritten offering of 9,900,990 common shares together with accompanying warrants to purchase an aggregate of 8,910,891 common shares at a combined price to the public of US$1.01 per share and accompanying warrant.

December 21, 2017

·

6 min read

Chicago's Attune Medical Scores $10M Series C

Fosun Pharma Unit to Raise $190 Million From New Share Issue

Shanghai Henlius will use the proceeds for its R&D and daily operations.

December 21, 2017

·

1 min read

Business

Kolon Life Science Faces More Headwinds on Its Gene Therapy As Partner Seeks to Cancel Deal

Kolon Life Science is facing more headwinds on its gene therapy for degenerative arthritis as a Japanese partner seeks to cancel a license deal signed last year due to negligent reporting on issues related to the late-stage drug candidate.

December 21, 2017

·

1 min read

Business

Xspray Pharma Enters Manufacturing Agreement With NerPharMa for its Lead Product Candidate - HyNap-Dasa

The agreement covers the clinical and world-wide commercial supply of HyNap-Dasa, and includes production of both drug substance and the finished product.

December 21, 2017

·

2 min read

Drug Development

MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports

Researchers found that voruciclib when combined with the BCL-2 inhibitor Venclexta was capable of inhibiting two master regulators of drug resistance, MCL-1 and BCL-2.

December 21, 2017

·

5 min read